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      Abstract 
Background: Palestine is experiencing a rapid health transition, with a large and rising burden 
of chronic diseases. Diabetes is considered to be one of the ten leading causes of death in 
Palestine. In Hebron district there are wide  net of community pharmacies that play a potential 
role in serving the diabetes patients .  
Objective: The main objectives of this research are to determine the needs required by the 
community pharmacists to enhance their practice in diabetes care, also to determine the nature of 
the common practices served by pharmacists for the diabetic patients and  the frequencies of 
common  activities related to diabetes , in addition to determine the main obstacles that impede 
pharmacists from playing the role in managing diabetic patients. 
Methodology: This is a cross sectional descriptive  study on community pharmacists in Hebron 
district, the tool of research was  customized questionnaire adopted from a credible Canadian 
research tool. 
Results: Pharmacists in Hebron district showed a good knowledge about diabetes, its 
complication , and  management. Pharmacists ‘often’ advised their patients to follow better diets, 
continually monitor blood glucose level,  guiding the patient about the importance of  foot care, 
informing them about the time to take medications, providing basic information about the 
importance of sports in monitoring their glucose level, guiding patients on the appropriate way to 
use insulin injections. In their pharmacies, pharmacists also routinely check diabetic patients 
medication and insure to be used appropriately and also identify a possible drug –drug 
interaction mostly with the over the counter medications. 
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Time constrains  and the lack of patient response to the advice were the major  obstacles reported 
by community pharmacists that impede them from giving the services   
Conclusion: Community pharmacists in Hebron district are experiencing a positive attitude and 
willing to help patients suffering from diabetes, there is an  importance of engagement of the 
community pharmacists in any future plan on the national level regarding any diabetes education 
programs ,also there is a need to improve the community pharmacists’ role in healthcare system 
by providing continuous education for them . 
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 دور الصيادلة في محافظة الخليل في علاج مرضى السكري 
 الطالب فراس محمد عرفات الدويكعداد: إ
 الدكتور محمد شاهين شراف:إ
  :الملخص
وخاصة مرض السكري والذي  مراض المزمنةالأجتمع الفلسطيني من كاهل وعبئ يعاني الم :خلفية البحث
 مهما   دورا  في محافظة الخليل الصيدليات المجتمعية  تلعب .الرئيسية للوفاة في فلسطينسباب حد الأأيعد من 
 .مرضى السكري في مساعدة وعلاج 
يقدمها الصيدلي لمرضى من الأهداف الرئيسية لهذا البحث هي تحديد نوع وطبيعة الخدمات التي : الهدف
 .و تمنع من تقديم هذه الخدماتأالتي قد تحد لى تحديد المعيقات إضافة بالإالسكري 
وقد تم استخدام على مجتمع من الصيادلة مسحية على مستوى محافظة الخليل  أجريت دراسة :المنهجية
   .  استبيان معتمد
يقوم الصيادلة  هفاتومضاعبمخاطر مرض السكري ن الصيادلة لديهم دراية وعلم أظهرت النتائج أ :النتائج
متعلقة بالحمية رشاد والنصح لهؤلاء المرضى المتعلقة بمراقبة مستوى السكر بالدم وتلك الغالبا بتقديم الإ
رشادات المتعلقة بحقن الأنسولين الإعطاء إب يضا يقوم الصيادلة غالبا  أ .سلوب حياة صحيأالغذائية واتباع 
المواظبة والالتزام بتناولها في للأدوية التي تعالج هذا المرض وكيفية سبة نبال يضا  أو ، وكيفية استعمالها
هم أ المرضى للنصائح هي في الغالب من ن ضيق الوقت وعدم استجابة أظهرت النتائج كما أ .وقاتهاأ
 .الخدمة بشكل جيد هو المعيقات لعدم تقديم هذأالأسباب 
يوجد ، الخدمات المتعلقة بمرض السكري بنسب متفاوتة: يقوم الصيادلة بشكل عام بتقديم معظم الخلاصة
ي برنامج مستقبلي يعنى بعلاج مرضى السكري على مستوى أفرصة جيدة لاستغلال القطاع الصيدلاني في 
 ن.الوط
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Chapter One 
 
Subject of Thesis 
 
1.1 Background 
 
Palestine is experiencing a rapid health transition, with a large and rising burden of chronic 
diseases, which are estimated to account for a large proportion of all deaths. Diabetes is 
considered to be one of the 10 leading causes of death in Palestine(Afshin et al., 2015). 
The dramatic increase in the number of new diabetes cases in recent years and the expected 
increases in coming years will place a strain on all health care professionals(Basile, 2000).  
Thus new and innovative methods and approaches to decrease the burden of the disease are 
needed. 
The concept of “total-patient care” and the approach of “multidisciplinary team work” are central 
principles in modern diabetes care(Martinez-Gomez, Moreno-Carrillo, Campillo-Soto, Carrillo-
Garcia, & Aguayo-Albasini, 2014).  
Patients’ empowerment and self-management mediated by education and motivation are one of 
the new important methods in this regards(Canadian Diabetes Association Clinical Practice 
Guidelines Expert et al., 2013) as they showed high level of success in controlling blood glucose 
level in diabetic patients.  
So in order that the aforementioned methods to be achieved; it would be more effective if 
support is delivered via readily accessible facilities such as community pharmacies.  
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According to the Palestinian Pharmacists Association (PPA) publishes; there are 1016 currently 
working community pharmacies in the west bank. However there were some studies that 
addressed the vital role of community pharmacists in Palestine(Al-Ramahi, 2013; Zaid, Al-
Ramahi, Shahed, Saleh, & Elaraj, 2012) . 
According to local cross sectional research study by Khodour et al in 2012, which aimed to 
determine the perception of Palestinian consumers of the community pharmacists and the 
services they offer, they found that the Palestinian consumers have a positive perception about 
community pharmacists and about their services,the researchers recommended to increase the 
awareness among the public about the role of community pharmacists(Khdour & Hallak, 2012). 
Pharmacists are the most accessible healthcare professionals to many chronically ill patients. It 
has been demonstrated that they see patients with diabetes up to five times more often than any 
other healthcare providers(Schapansky & Johnson, 2000). Additionally, pharmacists enjoy more 
free time than other medical practitioners and are usually accessible with no need for pre 
arrangements or to set an appointment.  
1.2 Research problem and significance 
 
The proposed research study aims to understand the exact role practices and activities concerning 
diabetes care management by Palestinian community pharmacists in Hebron district, located in 
the southern part of the West Bank. In Hebron, there is a wide network of community 
pharmacies which could potentially undertake a valuable supporting role in diabetes care, 
through direct interactive connection with the diabetics. 
Keeping in mind; that any future intervention that involves pharmacists; will definitely require 
deep understanding and to know the nature of activities and services provided by those 
pharmacists for their diabetic patients. 
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Additionally, conducting such a research would help to define pharmacist roles as part of the 
professional team that can  positively help in complementing the roles of others such as doctors, 
nurses, community health workers, lab technicians, dietitians, and others. 
This study, will focus on exploring the practices and activities of community pharmacists in 
supporting diabetic patients, in managing their diabetes in Hebron district. 
1.3 Objectives 
 
The main objectives for this research is to  
A. To determine the needs required by the community pharmacists to enhance their practice in 
diabetes care. 
B. To determine the frequencies of common activities and services served by the community 
pharmacists for the Diabetic patients. 
C. To determine the nature of the common practices served by pharmacists for the diabetic 
patients. 
D. To assess if there is a statistical relationship between the mentioned practices and the 
identified variables in the designed questionnaire. 
E. To determine the main obstacles that impede pharmacists from playing the role in managing 
diabetic patients 
 
1.4 Research Questions 
 
The research questions this study is aiming to address are: 
1: What are the current practices of community pharmacists towards diabetes and diabetic 
patients in terms of: 
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1. Causes and consequences 
2. The recently diagnosed new cases of diabetes. 
3. Early detection of new cases. 
4. Prescription and use of drugs(availability of antidiabetic medicines including insulin) 
5. Home care. 
6. Monitoring of patient condition. 
7. Foot care. 
8. Dealing with complications. 
9. Using alternative medicine. 
10. Referral of cases. 
11.  Others(any promotional material given from the community pharmacists to the diabetic 
patients). 
2: What is the status of services for diabetic patients served by community pharmacists in 
Hebron district. 
3. Is there a relationship between these practices and the followings? 
• Age 
• Gender 
• Years of experience 
• Professional qualifications 
• Previous training in diabetes management 
• Employer vs. employee at the pharmacy 
• Size of staff 
• Urban vs rural community pharmacists 
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4. What are the main obstacles that impede pharmacists from playing the role in managing 
diabetic management? 
 
1.5 Research hypothesis 
 
The hypotheses cover all potential independent variables. These variables included in Table(1) 
are derived from the literature and from the conceptual framework of the study in addition to the 
personal experience of the researcher. 
This study adopts the following hypothesis: 
1. There is an association (no statistically significant relationship) between the variable of 
pharmacist’s age and his/her role in the management of patients with diabetes. 
2. There is no association (statistically significant relationship) between the role of the 
pharmacist in the treatment of patients with diabetes and his/her work in another 
pharmacy. 
3. There is no association (statistically significant differences at the level of significance of  
(0.05) from the pharmacists point of view, regardingtheir role in the management of 
patients with diabetes are due to each of the following variables (gender, pharmacy site, 
relationship of  pharmacist to the pharmacy, previously taking  courses or training, 
attend conferences, read private medical journals, being a member in a  foundation 
specialized in the treatment of patients with diabetes) 
4. There is no significant differences at the level of significance (0.05) from the point of 
view of pharmacists about their role in the treatment of patients with diabetes are due to 
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each of the following variables (number of employees in the pharmacy, years of 
experience, age groups pharmacist). 
5. There is no statistically variation at the level of significance (0.05) from of pharmacists’ 
point of view, regarding their role toward diabetic patient care toward the following 
variables (age, number of workers in the pharmacy, years of experience). 
1.6 Definitions 
 
➢ Community pharmacists are the health professionals most accessible to the public. 
They supply medicines in accordance with a prescription or, when legally permitted, sell 
them without a prescription.(WHO) 
➢ Diabetic retinopathy is a diabetes complication that affects eyes. It's caused by damage 
to the blood vessels of the light-sensitive tissue at the back of the eye (retina). 
➢ Hypertension, also known as high or raised blood pressure, is a condition in which the 
blood vessels have persistently raised pressure.(WHO) 
➢ Diabetic neuropathy: Peripheral nerve damage from diabetes.(ADA) 
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Chapter Two 
 
Literature review 
 
2.1 Introduction 
 
There is a large volume of published literature on the evolving role of the community pharmacist 
in chronic disease management such as diabetes (Dhippayom & Krass, 2015) and hypertension 
(Tisdale, 2006). Many studies have demonstrated the effect of pharmacist intervention on the 
level HbA1c (Glycated Hemoglobin: form of hemoglobin that is measured to identify a three-
months average plasma glucose level) in diabetic patients (Butt, Mhd Ali, Bakry, & Mustafa, 
2016; Jahangard-Rafsanjani et al., 2015; Ko et al., 2016; Pinto, Kumar, Partha, & Bechtol, 
2014). There is an overall agreement that pharmacist intervention is a successful mean in 
reducing HbA1c levels in patients with type 2 Diabetes Mellitus (Al Hamarneh, Charrois, 
Lewanczuk, & Tsuyuki, 2013). The range of reduction in HbA1c is 0.5% - 3.4%. Accordingly, 
pharmacist intervention proved to be successful in improving patients glucose level in type 2 
Diabetes Mellitus and subsequently a reduction in diabetes complications (O'Donovan, Sahm, 
Shannon, & Byrne, 2011) . 
2.2 Diabetes and its complication 
 
According to the World Health Organization diabetes is defined as a chronic disease that occurs 
when the pancreas does not produce enough insulin, or when the body cannot effectively use the 
insulin produced.  Hyperglycemia, increased blood sugar, is a common effect of an uncontrolled 
diabetes and with the time leads to serious damage to many of the body's systems, especially the 
nerves and vascular systems (Kumar, Nandhini, Kamalanathan, Sahoo, & Vivekanadan, 2016; 
Marchesini et al., 2004). 
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In general, diabetes vascular complications are divided into two groups,microvascular which 
comes due to damage to small blood vessels and macrovascular which is due to damage to 
larger blood vessels. While microvascular complications include damage to eyes (retinopathy) 
which may lead to blindness, to kidneys (nephropathy) leading to renal failure and to nerves 
(neuropathy) leading to impotence and diabetic foot disorders,the macrovascular complications 
include cardiovascular diseases such as heart attacks, strokes and insufficiency in blood flow 
to leg(Chauhan & Sharma, 2016). In addition, neurological dysfunction may occur in most 
organ systems and can by manifest by constipation, diarrhea, bladder dysfunction, erectile 
dysfunction, exercise intolerance, resting tachycardia, silent ischemia, and even sudden cardiac 
death.(Maser, Mitchell, Vinik, & Freeman, 2003) 
 
2.3 Diabetes in Palestine 
 
In the Palestinian community, lifestyle changes, rapid urbanization and socioeconomic 
development, stress, smoking, and changes in food habits has increased the risk of non-
communicable diseases especially diabetes mellitus.(Rashed, Sabbah, Younis, Kisa, & Parkash, 
2016).According to the International Diabetes Federation there are almost 150,000 cases of 
diabetes reported in Palestine during 2015 with an estimated 12% prevalence among the 
Palestinian population(Abdul-Rahim et al., 2001). In addition, diabetes is considered to be one of 
major health problems among Palestinian refugees.(Shahin, Kapur, & Seita, 2015).The increase 
in the prevalence of diabetes in Palestine currently poses a large challenge to the Palestinian 
health care system(Abu-Rmeileh, Husseini, Capewell, O'Flaherty, & project, 2013). 
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2.4 Role of community pharmacists in diabetes management 
 
2.4.1 Pharmaceutical Practice toward Diabetes: 
 
Pharmaceutical care is defined as the pharmacist's contribution to the care of individuals in order 
to optimize medicines used in order to improve health outcomes. (Allemann et al., 2014). 
Optimizing drug use includes prevention or reduction of inappropriate drug usage and promoting 
patient’s self medication and literacy to achieve greater equality in healthcare, and the balanced 
sharing of responsibilities(Chung, Chua, Lai, & Chan, 2014). 
 
Pharmacist as part of their role as health care provider should be trained to identify the initial 
signs of diabetes and to refer the patients for appropriate medical examination. Pharmacists are 
also involved in detecting drug-related side effects and subsequently minimizing potential risks 
associated with improper use of medications(Monaghan & Monaghan, 1998). Moreover, 
pharmacist roles include achieving maximal patient drug adherence in order to improve patients 
quality of life (Monaghan & Monaghan, 1998; Vlcek, Maly, & Dosedel, 2009). 
A significant drop in HbA1c levels occurred, which showed that the involvement of a pharmacist 
in a health care team could improve patient results.(Brooks, Rihani, & Derus, 2007) 
 
Mehuys and colleagues have assessed the effectiveness of community pharmacist interventions 
in diabetic care in Belgium (Mehuys et al., 2011).The interventions mainly focused on correct 
use of medication, medication adherence, healthy lifestyle promotion, and changes in 
pharmacotherapy in 135 diabetic patients. Their results showed a significant reduction in HbA1c 
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levels(1.05%) in those patients whose pharmacotherapy plans were changed by a pharmacist’s 
intervention(Mehuys et al., 2011). 
 
In another study by Lim & Lim (2010), pharmacist role in managing diabetes was shown to be 
effective. A 43 diabetic patients whoseHbA1c level is >8% and completed eight visits were 
involved in the previous retrospective study at Penang Hospital in Malaysia. The level of HbA1c 
and glucose have been monitored during each visit. After completing the eight visits HbA1c 
FBG levels have been significantly reduced by 1.73% and 2.65mmol, respectively(Lim & Lim, 
2010). This reduction in Hb1Ac and FBG levels was associated with patient adherence to 
medication regimens. 
 
In another study by(Brooks et al., 2007) , which  intended to evaluate the clinical pharmacist’s 
role in a multidisciplinary health care team; included physicians, clinical pharmacists, registered 
nurses, and a registered dietician. Diabetic patients at multispecialty ambulatory care medical 
group in suburban Chicago were seen by clinical pharmacists for interventions; education, 
initiation, or adjustment of pharmacotherapy plans; and ordering of pertinent laboratory tests. 
 
Also; in another 53 week study, conducted in Massachusetts USA in 2007, to evaluate the 
outcomes of implementation of a pharmacist supervised at Veterans Affairs diabetic clinic.  
A total of 160 diabetic patients, who were taking either an oral hypoglycemic medication or 
insulin, were included in the study.  
The patients met with pharmacist after 12 weeks for review of clinical outcomes.  
A mean reduction of more than 1% (9.12% ± 1.41% to 7.94% ± 1.18%) in the HbA1c value was 
observed. 
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 Further HbA1c improvements were documented in patients followed for 6 months after clinical 
enrollment.  
This study revealed that a pharmacist’s intervention can have a positive impact on patient’s 
therapy outcomes.(Collier & Baker, 2014) . 
 
In a 6 month randomized(Mehuys et al., 2011), controlled, parallel-group trial with 135 diabetic 
patients was conducted in Belgium to assess the effectiveness of community pharmacist 
interventions in diabetic care.  
Patients at 66 community pharmacies were randomly assigned to receive a pharmacist’s care. 
The interventions mainly focused on correct use of medication, medication adherence, healthy 
lifestyle promotion, and changes in pharmacotherapy (ie, type and/or dose of hypoglycemic 
agents).  
The results showed a significant reduction (1.05%) in HbA1c in those patients whose 
pharmacotherapy plans were changed by a pharmacist’s intervention(Mehuys et al., 2011) 
 
 
 
2.4.2 Effects of community pharmacist intervention on Patient’s Knowledge 
 
The lack of knowledge about the DM ,its management and complications can be considered an 
important reason for improper control of DM.  
 
Education on self-management is the cornerstone of care for all patients with diabetes and is 
necessary for the improvement of Patient’s medical status. 
It is defined as an ongoing process of facilitating the knowledge, skill, and ability necessary for 
diabetes self-care(Funnell et al., 2007). 
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In a twelve months , non-crossover, single group trial(Berringer et al., 1999)on a group of 82 
diabetic patients at 2 independent community pharmacies in Richmond, Virgina. Patients 
received diabetic medication counseling, printed educational material, and instructions on dietary 
regulation, exercise, and lifestyle modifications from the community pharmacist. Average 
morning blood glucose levels decreased by 19.3 mg/dL at the end of 6 months (P = .07) and 29.3 
mg/dL at the end of 12 months (P < .05). 
The frequency of symptomatic episodes of hyperglycemia and hypoglycemia was significantly 
reduced in the intervention group.  
The data analysis indicated that pharmacist’s intervention has a positive impact on the  diabetic 
patients which were resembled by very good glycemic control, good health, and a good 
understanding of disease and its management at the end of study(Berringer et al., 1999). 
 
2.4.3 Effect on Diabetes-related Complications 
 
Diabetes complications could be disabling or even life threatening. These complications could be 
damage, dysfunction, and failure of various organs, specifically the eyes, kidneys, nerves, heart, 
and blood vessels.  
 
One retrospective study(Kiel & McCord, 2005) with 157 diabetic patients was conducted to 
evaluate changes in clinical outcomes for patients enrolled in a pharmacist coordinated diabetes 
management program, the study was conducted between June 2003 and April 2004.  
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The program was housed in a multispecialty physician group practice within a managed care 
environment. 
Twenty two physicians held practice agreements with two clinical pharmacy specialists. Data 
collection included baseline (within 6 mo of enrollment) and follow-up values for HbA1cand 
lipids as well as frequency of annual foot, eye examinations and also micro albumin screening.  
Significant improvements were observed in HbA1c and LDL values. 
 The frequency of micro albumin screening increased by 27% (P < .001), and the number of 
patients with annual eye and foot examinations increased by 27% (P < .05) and 15% (P < .05), 
respectively.(Kiel & McCord, 2005) 
 
Another nonrandomized, prospective study(Cioffi, Caron, Kalus, Hill, & Buckley, 2004) 
spanning 9 to 12 months was conducted in 70 Veterans affairs patients to determine the effect of 
a clinical pharmacist who directed diabetes management clinic on glycemic control, as well as 
cardiovascular and renal parameters, in patients with type 2 diabetes.  
Patients met with pharmacist every 6 to 8 weeks for approximately 30 minutes for education, 
medication counseling, monitoring, and management.  
The HbA1c level significantly decreased (P < .001) during the 9 to 12-month evaluation period.  
2.4.4Effects on foot care and retinal examination 
 
The Diabetic foot is considered as one of the most serious and dangerous complication that may 
resulting from this disease. One study (Nowak, Singh, Clarke, Campbell, & Jaber, 2002)reported 
an increase in the number of patients having regular foot examinations. The study was conducted 
at an ambulatory, multispecialty physician group practice within a managed care environment in 
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suburban Chicago in the USA.  A total of 316 patients with DM were referred to a clinical 
pharmacy service for interventions.  
Drug therapy management and education services were provided by a clinical pharmacist. A total 
of 316 patients were referred to the clinical pharmacist from October 2001 to June 2002.  
 
Frequency of annual dilated retinal examinations and monofilament foot examinations increased 
by 29% (P < .05) and 12.5% (P < .05), respectively(Nowak et al., 2002) . 
 
 
2.5Asheville Project 
 
The Asheville Project is considered to be one of the most important projects that highlight the 
importance of the role of community pharmacists in diabetic management(Cranor, Bunting, & 
Christensen, 2003).It is a progressive pilot project, which was launched in 1997 by the city of 
Asheville-North Carolina, provided education and personal over site for city employees with 
chronic health problems, such as diabetes. Through the project duration; trained pharmacists hold 
face to face meetings with employees with diabetes to educate, motivate, and empower the 
employees to better manage their condition with resultant improved health status and reduced 
diabetes associated costs.  
The essential elements of the Asheville model included; a network of specially trained 
community pharmacists to whom employees with diabetes made regular visits for care 
monitoring and counseling, employer payment to pharmacists for pharmaceutical care services. 
 
Pharmacists have performed a variety of patient specific tailored services that included:  
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a)Setting and monitoring diabetes treatment goals. 
b) Adherence strategies, 
c) Performed physical assessment of patient’s feet, skin, blood pressure, and weight. 
d) Referring patients to their physician or diabetes education center as needed. 
e) Home glucose meter training, 
f) Diabetes and lipid management education. 
 
 
2.6The clinical and financial outcomes for the Asheville project 
 
First the mean HbA1c values and lipid levels of program participants has been  decreased, with 
more than 50% of participants demonstrating improvements at every measurement, 
Second;  at the first six month follow up, 24.3% more patients had optimal A1c values (<7.0%) 
compared to baseline values (increases of 27.2% and 18.2% more patients were noted at the 
second and third six month follow ups, respectively). 
Third; there was a decrease in the emergency department visits at a rate that is one to third the 
national average, 
Fourth; the employer program sponsors has realized decreases in total direct medical costs. 
Finally employer return on investment was four to one for diabetes patients.(Cranor et al., 
2003) 
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2.7 Conclusion of literature review 
 
The aforementioned reviews indicate that;a pharmacist intervention offers a potential benefit to 
reduce levels of HbA1c. In addition; it improves medication adherence in diabetes, and it lowers 
the diabetes related complications significantly. The review also; finds evidence that metabolic 
control of diabetes can be affected by a patient’s knowledge of the disease.  
A community pharmacist, can improve to a distinguished level, not only adherence but also 
patients satisfaction and quality of life. The review also emphasizes that medication management 
or intervention programs of the aforementioned studies by pharmacists provide improvements in 
clinical, humanistic, and financial outcomes for patients with a chronic disease. Finally 
Pharmacist integration into a health care team has proved to be effective in improving a number 
of clinical health outcomes.  
However; it was hard to find similar researches to the subject of this thesis, due to the few 
conducted related studies, which resulted in limiting the overall conclusion. 
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Chapter Three 
 
Theoretical framework 
 
The available literature on pharmacist role in diabetes management has thus far focused on 
individual factors related to the education, training, and experience of the pharmacist with less 
focus on the societal factors that influence the role of the pharmacist (e.g. the location of the 
pharmacy in an urban or rural area). This research combines both individual factors and societal 
factors.  
Adopting the pharmacist-led chronic disease management model Figure(A), we can see that the 
research addressed pretty much the same pillars. The model identified 70 papers (published from 
1995 to 2015), representing 62 studies of 64 unique study populations(Greer et al., 2016). 
The model address the chronic disease studies, including cardiovascular disease, diabetes, 
depression, and hypertension) enrolling 34457 patients.  
This model has been selected in order to help achieving research objective and also to organize 
the ideas. 
An evidence of moderate-strength indicates that pharmacist-led chronic disease management 
increases goal attainment for HbA1c, blood pressure, and cholesterol levels. 
Moderate- or low-strength evidence also indicates that pharmacist-led chronic disease 
management and usual care were similar for urgent care visits or hospitalizations, clinical events, 
and adherence to medications. Evidence was insufficient for patient satisfaction 
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Components of Pharmacist-Led Chronic Disease Management 
By (Greer et al., 2016) 
a. Medication Monitoring: follow-up after prescription for medication effectiveness and 
safety, drug-related problems  
b. Medication Therapy Review: includes medication reconciliation  
c. Immunizations: pharmacist provides immunization; immunization was not an outcome of 
interest  
d. Disease Self-care and Support: facilitate access to other health care professionals; 
education about disease, lifestyle changes; aspirin therapy; tobacco cessation 
 
Figure A: Chronic disease management  
chornic 
disease 
management 
pharmacist-led 
intervention
a. Medication 
Monitoring
b. Medication 
therapy review
Patient 
medication 
education
c. 
immunizations
d. Disease self 
care and 
support
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Chapter Four 
 
Research Methodology 
 
4.1 Research design 
 
This is a cross sectional study, designed to measure the current practices of community 
pharmacists in Hebron district toward diabetes management. 
4.2 Description of the location of research 
 
Hebron District is the largest district in the West Bank with around 650000 inhabitants, 
according to the Palestinian Central bureau of Statistics (PCBS) last updated in 2011.  
The District constitutes around 16% of the total area of the west bank. The research 
questionnaire was filled with a representative sample of pharmacists, who are working in the 
community pharmacies of Hebron district. 
An updated list of the names and location of the community pharmacies has been obtained from 
the Pharmacists Association which indicated the presence of nearly 203 community pharmacies 
in Hebron District (villages and city) 
There are 203 community pharmacies in Hebron District: 130 in rural areas and 73 in urban 
areas. An average 1-2 pharmacists and aid pharmacists work in each pharmacy. 
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4.3 Sampling and selection method 
 
A sample size of 130 out of 203 pharmacists was identified. Nevertheless; only a 100 
questionnaire were filled by 100 pharmacists, representing 49.2%   of the community 
pharmacists in Hebron district.  A sample has been chosen out of the list of community 
pharmacies obtained from the pharmacists association which indicated the presence of nearly 
203 community pharmacies in Hebron District (villages and city) based on this list a sample has 
been chosen  
4.4 Research tools 
 
The research’s main tool is a questionnaire that has been adopted  from a credible Canadian 
research tool (Survey of Pharmacist Activities and Attitudes in Diabetes Management) by Scot 
H. Simpson, BSP, PharmD, MSc(Simpson et al., 2009) . 
The questionnaire has been customized in order to make it suitable for the local Palestinian 
community pharmacist. Some questions that are not compatible with the Palestinian context were 
removed in order to adapt to the local Palestinian pharmaceutical status(i.e alcohol consumption) 
The customization process has been done in cooperation with some experienced community 
pharmacists who has a good knowledge and practice in this field. The process came up 
eventually with the identification of the ten main variables. See Annex 2, Table (1). 
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4.5 Questionnaire description 
 
The questionnaire is divided into three sections  
 The first section is concerned with demographic variables related to the working community 
pharmacists in Hebron district.The second section is concerned with pharmacy practice related to 
diabetic patients, while the third section is mainly asking about the activities and services which 
are served by community pharmacists to diabetic patients these are 51questions which were 
divided into 8 major fields which measure the following:  
The first field is related to the early detection of new cases of diabetes, the second measures if 
the pharmacists are doing blood sugar detecting test for their patients, the third measures the 
interventions for treating hypoglycemic patients,  the forth  measures the medication treatment in 
general, the fifth is concerned with the insulin treatment and the sixth is medication taken orally, 
the seventh is concerned with treatment of the accompanying diabetic chronic 
diseases(Hypertension), and the eighth field is concerned with health life style for the diabetic 
patients. 
The scale of answers is leveled from” I do not offer” to “always” 
4.6 Coding of answers: 
 
The answers to third paragraph were given the following weights:  
“I do not offer”    (1) degree      
The answer “rare”                      (2) degrees                                                                   
 The answer “often”               (3) degree  
The answer “always”     (4) degrees 
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The calculation of the correction key of the questionnaire has been done as following: 
Constitute the degree of availability of services expressed by paragraph always from the 
standpoint of respondents if the average ranged arithmetic paragraph is of value between 3.28-4, 
and is considered often if the average ranged arithmetic paragraph is of value between 2.52-3.27, 
and is to be considered as rarely if average ranged arithmetic is of value 1.76-2.51.  
The option “do not offer "is considered if the arithmetic average ranged paragraph is of value 
between 1-1.75. 
 
4.7 Data and statistical analysis 
 
After data collection; this study has been reviewed in preparation for the analysis purpose.The 
analysis was conducted using statistical analysis software, through giving specific figures for the 
responses, considering converting the verbal responses into digitalized values to facilitate the 
analysis. 
The Processing of statistical data extracted frequencies, percentages, averages and standard 
deviations. The T test per set and this has been done by using the statistical software packages 
Statistical Package for Social Science (SPSS). 
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4.8 Sample Description 
 
The sample constitutes of 100 community pharmacists respondents, with a demographical 
distribution of 57% from villages and 43% from Hebron city. On the other hand; the gender 
distribution of the sample was 75% males, and 24% females with a missing reply of one 1% . 
Age groups where distributed in three age categories; category one is between 23 -30, category 
two is between 31 -40, and category three is above 41 years old.  
When talking about the university degree the B.A holders were the majority of respondents with 
89% percentage while the master degree holders were 7% and the PhD holders were 2%.  
Regarding years of experience: 
18 percent of the respondents regarding years of experience (YOE) had an experience between 1 
to five years while 23 percent had 6 to years of experience, 26 percent had an experience 
between 11-15 years while 8 percent had an experience more than 15 years. 
Regarding the Ownership 64 percent were owner of the community pharmacies while 30 percent 
worked as employee. 
 
4.9 Piloting 
 
The study tool was applied on a prospective sample, consisted of thirty pharmacists of the study 
population, and it has been observed that the questionnaire was clear and the respondents did not 
have any notes or complains about it. 
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Stability of the tool has been measured through the implementation of two main methods, that 
are: 1) internal consistency measurements (Cronbach's alpha)to the questionnaire dimensions, 
which consists of “51”paragraphs.2) the split half method. 
The following table (i), shows the Cronbach’s Alpha and the split half coefficient for the 
questionnaire  
Split-Half Coefficient Cronbach’s Alpha Answers .n N of Items 
905. .965 30 55 
Table (i): cronbach’s Alpha and the split half coefficient 
 
 
The above table; shows that tool Cronbach Alfa has a high positive value at the time the split half 
coefficient has also a positive and high value ,this enables the questionnaire to be used for the 
research purposes which has been built for .  
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Chapter Five 
 
Research Results 
 
5.1 Introduction 
 
This chapter includes a comprehensive description, for the obtained results that meant to answer 
the research questions and research objectives, also to test the validity of its hypothesis by using 
the previously mentioned tests (in chapter four), which also will be furthered discussed  
5.2 Research Questions and Answers 
 
All referral tables of analysis are listed in Annex 2. 
 
Q1: What are the current practices of community pharmacists towards diabetes and diabetic 
patients in terms of: 
1. Causes and consequences 
2. The recently diagnosed new cases of diabetes  
3. Early detection of new cases. 
4. Prescription and use of drugs(availability of anti-diabetic medicines including insulin) 
5. Home care 
6. Monitoring of patient condition 
7. Foot care 
8. Dealing with complications 
9. Using alternative medicine   
10. Location of the pharmacy(urban, rural) 
11. Referral of cases 
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To answer this question (Q1), the frequencies and percentages for variables of pharmaceutical 
practice were measured. 
As noted from table (2):Pharmaceutical practice related to diabetes; that 26% of the pharmacists 
has attended courses related to diabetes management while 36% of the pharmacists has answered 
that they have attended and participated in conferences related to diabetes, on the other hand 
47% of the pharmacists read medical journals and articles related to diabetes based on regular 
base, while only 20% of the pharmacists are members of organizations and committees that takes 
part regarding the diabetes management.  
In additions the mean and the standard deviations has been calculated for each subject of the 
questionnaire and has been ordered in accordance with the degree of acceptance. 
A review of the results shown in table (3):(Activities held by pharmacists toward diabetic 
patients);pointed out that the respondents agree on the role of the pharmacist in diabetes 
treatment significantly(PV= 0.05) (often) as the average total score for answers subjects (2.7905) 
with a standard deviation (0.5967) and this reflects the status of many services provided by the 
pharmacists in Hebron district. See table (3) 
This also includes guiding the patient about the importance of foot care, counseling patients on 
the normal levels of glucose in the blood, in addition providing basic information about the 
importance of diet for diabetics, informing the patient about the time to take medications, and 
providing basic information about sports. Where these are considered as positive impact on 
patients with diabetes, guiding patients on the appropriate way to use insulin injections. and 
how to get rid of it ,explaining  to the patient the risks of high  blood pressure on  patients with 
diabetes , counseling patients on the appropriate way to use insulin pens and how to get rid of 
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them, explaining  the risk of diabetic retinopathy, counseling patients on the appropriate times 
to check blood glucose. These services which are provided to patients with diabetes were 
ranked from one to ten by grade. 
While there were some  services that were rarely (seldom)offered by  pharmacists the following 
services for patients with diabetes from the use of alternative medicine such as herbal 
preparations and natural, diagnosing  symptoms secondary to the disease after the discovery of a 
case, referring patients with diabetes to a social worker, referring a patients with diabetes to an 
educational program about the disease, and doing routinely check the blood glucose for the 
undiagnosed cases in the pharmacy 
Answering the question of  
Q2:What is the status of services provided by the pharmacist for diabetic patients? 
To answer the question the averages and the standard deviations were calculated for all 
paragraphs of the questionnaire, and the order of the paragraphs of each resulted value in 
descending order according to the degree of approval shown in Tables (4,5,6, and 7) of the 
pharmacists practices between the results of the analysis 
Reviewing the results shown in Table 4, it is noted that respondents  agree about the  role of the 
pharmacist in early screening for diabetes significantly (much) as the average total score for 
answers subjects (2.5260) and standard deviation (0.71104), where often advised patients with 
overweight, to reduce their weight through following better diets, and advised to consider diets 
with low sugar ratio (beans, lentils, oatmeal, fruit unsweetened) as a source of carbohydrates in 
their diet, and alerting people exposed to the disease or diagnosis of pre-diabetes and tutor to 
adjust the pattern life. 
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While rarely pharmacists diagnose secondary symptoms of the disease after the discovery of a 
new case, and rarely do a blood test for undiagnosed cases at their pharmacies and this could be 
due to lack of time. 
Results shown in Table 5 that pharmacists often in monitor blood glucose for diabetic patients, 
with an average total score for answers subjects (2.822+) and standard deviation of  (0.73802), 
where often pharmacists advice patients on the normal values of glucose in their blood, and the 
appropriate times to check glucose in blood, Counsel on the appropriate times to check blood 
glucose, and to identify possible causes of the values of abnormal blood glucose, and help 
patients interpret measurements examine the cumulative diabetes HbA1C, and recommend drug 
therapy for a doctor to help patients to achieve the desired goals for blood sugar. 
Analyzed figures in Table7; shows the role of the pharmacist in a historic evaluation (drug 
history: which pharmacists are especially suited to conducting medication history interviews, as 
they are familiar with drug names, effects, dosage forms, and administration than other health 
care personnel. They can readily identify inconsistencies and mistakes in patients' self-reported 
medication histories. They also  have the expertise and experience to optimize a patient's drug 
therapy through clinical interventions)(Badowski, Rosenbloom, & Dawson, 1984). 
This includes medicines coupled as an average total score for answers subjects (2.5670) and 
standard deviation (0.90031) where occupied paragraph (47) and to standard pharmacists to 
dispersion in the practice of this role. 
Pharmacist has shown positive attitude toward the appropriate use of medication which was 
mainly by providing patient-specific interventions to help improve adherence in addition to 
counseling about the cautions of over-the-counter drugs (OTC), and identify the barriers for good 
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drug adherence which is defined as the extent to which patients take medications as prescribed 
by their health care providers(Osterberg  & Blaschke 2005). See Table 8: Diabetes Management. 
Pharmacists has shown positive attitudes towards counseling their customers on the appropriate 
use and administration of insulin products that include the proper use ,timing ,and explaining for 
them about the use of insulin needles and syringes  however these results are clearly shown on 
Table 9. 
On the other hand pharmacists show positive attitude and welling to discuss for their patients 
about the proper use of oral anti diabetic medication that include appropriate time for taking the 
medication ,mechanism of action of these medication and about possible adverse effects that may 
affect these patients (Table 10) 
Pharmacists; has also shown a positive attitude toward dealing with the complication that may 
accompany the diabetes (like hypertension). This was highly reported in providing education on 
the importance of controlling blood pressure in diabetes, guiding the patient about the normal 
blood pressure measurements, counseling their customers on the risk factors for both retinopathy 
and nephropathy in diabetes were also highly reported. See Table11. 
Pharmacist are giving advices often for the patients about good foot care techniques, and 
counseling their patients on how to deal with symptoms of the neuropathic pains that may arise. 
Also they address for their customers about the importance of regular screening for the 
neuropathic pains Table 12. 
Regarding the life style modification aspect; it was noticed that a frequently advices and education was 
provided to diabetic patients. This was mainly provided through basic information on proper diet and 
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exercises, in addition of advising smokers regarding the risk of smoking of continued tobacco use. See 
Table 13. 
Q4.what are the main obstacles that impede pharmacists from playing the role in managing 
diabetic management? 
As reported; time constrain was the mostly reported one with frequencies of 31 respondents 
while the lack of patient response to the advice came in the second rank of respondents with 
frequencies of 30 respondents, at the fourth order the lack of incentive was reported as one of the 
main obstacles that impede these pharmacists in dealing with diabetic patients. Table(A) 
The following points were reported with frequencies less than 10  
• Lack of training and lack of patient response to advise  
• The lack of qualified medical teams 
• Lack of patient’s follow up 
• Lack   of programs for supporting diabetic patients 
• The existence of weak health care system that doesn’t offer the appropriate care for 
patients 
5.3 Research’s’ answers of hypothesizes (Q.3) 
 
❖ First Hypothesizes: To test the validity of the following null hypothesis: 
There were no statistically significant relationship between the variable of age groups and the 
role of the pharmacist in the treatment of patients with diabetes. 
The chi-square test has been used in order to determine a relationship between two variables 
(age of the pharmacist, the pharmacist's role in the treatment of patients with diabetes). 
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Noted from these results that the value of chi-squared (29.421) function is statistically significant 
at (α≤ 0.01), reaching P value= (0.001), and therefore the null hypothesis is rejected, meaning 
that there are differences between the expected and the real cumulative and these differences are 
statistically significant and is no longer to serendipity factor, which means that the role of the 
pharmacist in the treatment of diabetic patients is being  affected by the  age. 
❖ Second hypothesis: To test the validity of the following zero hypothesis: 
There was no statistically significant relationship between the role of the pharmacist in the 
treatment of patients with diabetes and his working in another pharmacy variable. 
The chi-squared test has been used to determine a relationship between two variables (the role of 
the pharmacist in the treatment of patients with diabetes, the work of the pharmacist in another 
pharmacy). 
It is Noted from these results that the value of chi-squared (37.586) function is statistically 
significant at (α≤ 0.01), reaching P value =0.001), and therefore the null hypothesis is rejected, 
meaning that there were differences between the expected and the real commutative and these 
differences are statistically significant and no longer to serendipity factor, which means that the 
role of the pharmacist in the treatment of patients with diabetes is influenced by his work in 
another pharmacy 
❖ Third hypothesis: to test the validity of the following zero hypothesis: 
There was no statistically significant differences at the level of significance of (0.05) from the 
point of Pharmacists of view about their role in the treatment of diabetes patients are due to each of 
the following variables (pharmacy site, relationship of pharmacist to the pharmacy, previously 
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taking courses or training, attend conferences, read private medical journals, being a member in a 
foundation specialized in the treatment of patients with diabetes). 
According to the results there was a non-statistically significant differences at the level of 
significance (0.05) from the pharmacists point view in accordance about their role in the treatment 
of diabetic patients due to the variable sex as the value of "T" (0,778)which is a not statistically 
significant, which means that male pharmacists are not different from females in their role in the 
treatment of patients with diabetes. 
But on the other hand  the results show a presence of statistically significant differences at the level 
of significance (0.05) from the point of view of Pharmacists about their role in the treatment of 
diabetic patients due to the variable of  pharmacy site , pharmacists in the villages for the benefit of 
reaching T (2.419), a statistically significance, especially with regard to the treatment of 
hypoglycemia , and treatment of diseases associated with diabetes, and take care of diabetic foot, 
and referring  cases to specialists, which means that pharmacists in the villages have more positive 
performance of their role in the treatment of patients with diabetes for pharmacists colleagues of 
those in the urban communities. This could be due to the availability of specialists in the city, and 
the hesitation of patients in the villages of going to the physician. Also it could be due to the more 
time availability (free time), that the pharmacists have in rural areas, but lack of time, and more 
life pressure lies on pharmacists in the urban areas. 
Also the results show a non-statistically significant differences at the level of significance (0.05) 
from the point of Pharmacists of view about their role in the treatment of diabetic patients due to 
the variable pharmacist (owner\ employees) as the value of "T" (0,309) which is a non-
statistically significant. This means that the pharmacies’ owners and the non-owner pharmacists 
do not differ from pharmacists’ staff in their role in the treatment of patients with diabetes. 
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While the results indicates  the presence of statistically significant differences at the level of 
significance (0.05) from the point of view  Pharmacists about their role in the treatment of 
diabetic patients due to the variable of receiving training courses for the prevention and treatment 
of diabetes , pharmacists who are enrolled in these courses for the benefit of reaching "T" value 
of (1.997),which is a statistically significant value, especially with regard to refereeing  of the  
cases to the specialists, which means that the pharmacists who are enrolled in training courses 
will refer the diabetic patients to specialists more than their colleagues who did not attend these 
courses . 
In addition; there is a non-statistically significant differences at the level of significance (0.05) 
from the point of view Pharmacists about their role in the treatment of diabetic patients due to 
the variable of degree of the pharmacist as the value of "T" (0,850) which is  a non-statistically 
significant, which means that pharmacists who hold graduate degrees do not differ from 
pharmacists who hold bachelor's degrees in their role in the treatment of patients with diabetes. 
This may be due to the small size of sample of the upper degrees where the number of masters 
holders are seven pharmacists, and the number of Doctorate certificates holders are two 
pharmacists. 
Also; and according to the findings, there were non-statistically significant differences at the 
level of significance (0.05) from the point of Pharmacists of view about their role in the 
treatment of diabetic patients due to the variable of attending a conference related to treating of 
diabetes as the value of "T" (0.747.) which means that pharmacists who attended the conference 
do not differ from pharmacists who did not attend conferences related to treatment of diabetic 
patients. 
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The results show presence of statistically significant differences at the level of significance 
(0.05) from the point of view Pharmacists about their role in the treatment of diabetic patients 
due to the variable of reading medical journals about diabetes in  periodic times, in other words 
pharmacists who read medical journals has a score  of "T" (2.384)which a statistically 
significant, especially with regard to the treatment of hypoglycemic patients, besides treatment of 
diseases associated with diabetes, in addition to the treatment of patients with diabetes who use 
oral  medication and the early detection and prevention of diabetes treatment. 
The results did not indicate differences at the level of significance (0.05) from the point of view 
of the pharmacists, regarding their role in the treatment of diabetic patients due to the variable of 
participation in any organization or association which  has a role in the treatment of diabetes ,as 
the value of  "T "(0.587) which a non-statistically significant value. This means that pharmacists 
who are participants in such organizations are not different from their colleagues of non-
participants pharmacists. 
❖ Fourth hypothesis: to test the validity of the following zero hypothesis: 
There is no significant differences at the level of significance (0.05) from the point of view of 
pharmacists about their role in the treatment of patients with diabetes are due for each of the 
following variables (number of employees in the pharmacy, years of experience, age groups 
pharmacist). 
To answer the fourth hypothesis test a unilateral variation of the following three tables and 
analysis of results of the analysis show 
It was found that there were no statistically significant differences at the level of significance 
(0.05) from the point of view of Pharmacists about their role in the treatment of diabetic 
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patients regarding the variable of number of employees in the pharmacy, where the value of f 
reached ((2.032 ), which means that pharmacists do not differ in their role in the treatment of 
patients with diabetes depending on the number of employees in the pharmacy. On the other 
hand the post-test groups heterogeneous LSD showed the existence of differences between 
the third group (more than 2 employees) and the second group (2 employees only) in the 
following four areas: glucose control in the blood and the treatment of diabetes, drug therapy 
for patients with diabetes who use insulin and the early detection of diabetes in favor of the 
existence of more than those working in the pharmacy. 
Post-test groups heterogeneous also showed the existence of differences between the third 
group (more than employees) and the second group (employees only) in the following three 
areas: controlling glucose in the blood and drug therapy for patients with diabetes who use 
insulin and the early detection of diabetes in favor of the existence of more than workers in 
pharmacy. 
This may be due to the fact that every worker may think that his colleague had the expected 
role instead of him. 
On the other hand it was found that there were no statistically significant differences at the 
level of significance (0.05) from the point of view of Pharmacists about their role in the 
treatment of diabetic patients and the variable age groups pharmacists, amounted value of f 
(.0853) which is not statistically significant, which means that pharmacists do not differ in 
their role in the treatment of diabetic patients within different age categories. 
However it has been found that there is a statistically significant relationship role of the 
pharmacist in the treatment of patients with diabetes and the years of experience of the 
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pharmacist. The relationship has been reached (0.649) between the role of the pharmacist in 
the treatment of patients with diabetes and years of experience between the pharmacist and a 
positive relationship medium, which means that the more years of experience pharmacist 
reflected positively on his/her role in the treatment of patients with diabetes. 
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Chapter Six 
 
Discussion and Conclusion 
 
6.1 Questionnaires’ answered analysis 
 
The community pharmacist role is not only limited to dispensing prescribed medicines.  
Pharmacists are skilled at identifying adherence problems and addressing adverse drug effects, 
and many pharmacists are trained to educate and motivate patients on diet, exercise, and diabetes 
self-care activities(George, Molina, Cheah, Chan, & Lim, 2010). 
In addition they  can also identify adherence problems and manage adverse drug effects besides 
they have a significant training in the pharmacotherapy of diabetes and cardiovascular disease 
and can make valuable drug therapy recommendations to physicians ,in addition many 
pharmacists are trained to educate and motivate patients on diet, exercise, and diabetes self-care 
activities.(Doucette, Witry, Farris, & McDonough, 2009) 
However in this section; a coherent discussion is meant to take place for this study;to highlight 
the current community pharmacists’ role and practices toward diabetes management, based on 
the results of the research questions, and going through a description of these activities and its 
extent. Then; a further discussion will be focused on the research hypothesis. 
It was clear that the aforementioned practices and activities are undertaken by pharmacists in 
different degrees and extents and they were resembled and described as follows: 
The recently diagnosed new cases of diabetes: Apparently; pharmacists are doing activities in 
often way regarding this issue, mainly by giving advices for the overweighed patients, to 
enhance their eating habits, to reduce their weight, including tailored advices to carefully select 
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food with low sugar ratio. Also; alerting people exposed to the disease or diagnosis of pre-
diabetes and guide them to adjust their life pattern and this complies with a research held in 
Nigeria (Bello, Ganiyu, Dakop, & Erah, 2012) ,also to another study in Pakistan (Zia ur, Khan, 
Gaohar, Baig, & Khan, 2014) . 
While rarely pharmacists diagnose or give education about secondary symptoms of the disease 
following the discovery of a new case, and rarely do a blood test for undiagnosed cases at their 
pharmacies and these findings are similar to the finding of (Shatnawi & Latif, 2016). 
This could be due to lack of time and the absence of blood sugar monitors in their pharmacies, or 
could be due to that pharmacists may belief that this is a responsibility of other health 
professional. 
Results shown the role of the pharmacist often monitor blood glucose for diabetes, where often 
pharmacists advice patients on the normal values of glucose in their blood, and the appropriate 
times to check glucose in blood, Counsel on the appropriate times to check blood glucose, and to 
identify possible causes of the values of abnormal blood glucose, and help patients interpret 
measurements examine the cumulative diabetes HbA1C. 
Results have indicate that; Pharmacists often give advices to their patients, regarding the proper 
dealing with the diabetes complication. This has been clearly shown in the related activities by 
providing education about the importance of controlling and monitoring blood pressure that may 
be accompanied with diabetes. Also a role in counseling on the current treatment targets for 
blood pressure, in addition to provide education on the importance of regular screening for 
retinopathy. 
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The issue of giving advices and counseling regarding the proper using of alternative medicine 
were rarely served by these community pharmacists, so when talking about the proper use of 
herbal medication Pharmacists has shown a weakness in this field,  and this may be due to lack 
of knowledge about the mechanism of action of these products and its proper use, however this 
result complies with a result of local cross sectional (Community Pharmacists' Medication 
Knowledge: A Nation-wide Study in Palestine) that show a similar result about such weakness of 
knowledge about these herbal products use. 
The issue of patient referral to a specialist is considered to be one of the most important aspects 
in the role of pharmacists in diabetes management. (Campbell, 2002)It has been noticed however 
in this study, that pharmacists show a weakness in this field and this finding was similar to the 
finding of (Bhojani et al., 2014),and this weakness has been shown especially when referring to a 
social worker and this could be due to mainly the lack of institutions and personnel (not popular) 
that serve such services for the diabetic patients, on the other hand; there were rarely reporting in 
referral to a diabetic educational program and this could be due to the lack of awareness of the 
presence of these programs within the pharmacists populations. 
Nevertheless the most commonly referral by the Pharmacists was referring to an 
Ophthalmologist, however this finding is similar to the finding of (Jimenez-Ramirez & Perez, 
2011), and  this could be due to the fact that eye diseases are the most common problems during 
diabetes. Table 14. 
When discussing the obstacles that impede the community pharmacist from offering the services 
for the diabetic patients, time constrain came in the first rank, and it was obvious that community 
pharmacist who has less pressure of work has much more time of serving such services ,lack of 
patient response came in the second rank and this could be due to  that   patients has lack of 
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awareness about the medical advices and some still perceive that medicines supply remains the 
principal role of the community pharmacist, lack of incentive or compensation  came in the third 
rank because in most of time patients doesn’t pay for these services most of time seeking to 
dispense their medication from the pharmacies that offer the lowest prices and don’t appreciate 
the  quality of services they receive ,however these main barriers were also reported in several 
studies worldwide one study was in Iowa (Barriers to Community Pharmacists' Provision of 
Diabetes Care Services in Iowa(Plake, Chesnut, & Odorzynski, 2007) in which reimbursement, 
work load and lack of time were the most reported barriers. 
However; extra research is still required in this field, in order to address the obstacles, and 
underline the importance of having a deep knowledge concerning the reasons stand behind them. 
 
6.2 Hypotheses analysis 
 
The analyzed hypotheses showed that the demographic variables have different and varied 
impacts on the role of Pharmacists in Diabetes management. Commencing with age variable; it 
has been noticed that Pharmacist role in diabetes management is affected by age and this could 
be due to accumulative experience they have. 
The gender responses; did not have any resulted difference wither this service is given by a 
female pharmacist or a male Pharmacist. 
Community pharmacists in the rural areas have shown preference in giving the diabetic activities 
over those in the urban areas especially with regard to the treatment of hypoglycemia(low blood 
glucose) and this complies with findings of (Ryan et al., 2012), treatment of diseases associated 
with diabetes, taking care of diabetic foot which complies with findings of , and refereeing  the 
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cases to specialists, which means that pharmacists in the villages differ in the performance of 
their role in the treatment of patients with diabetes for pharmacists colleagues in the urban 
maybe  it was due to the availability of specialists  in the city, and the hesitation of patients in the 
villages of  going to the doctor, also it could be due to the longer time that the pharmacists have 
in the rural areas . 
The ownership of the pharmacy hasn’t shown a significant difference in providing the diabetic 
services, which means that the owners of pharmacies and the non-owner pharmacists do not 
differ from pharmacists staff in their role in the treatment of patients with diabetes. 
pharmacists who were  enrolled in courses related to diabetes management has shown preference 
in providing these services over the pharmacists who didn’t and this finding is similar to the 
finding of (Simpson et al., 2009) , especially when talk about  refereeing  the  cases to the 
specialists, which means that the pharmacists who are enrolled in training courses will  transfer 
the diabetic patients to specialists more than their colleagues who did not attend these courses . 
The obtained university degree of the community pharmacists, has not played a role in providing 
these services, which means that pharmacists who hold master or PhD degrees do not differ from 
pharmacists who hold bachelor's degrees in their role in the diabetic patients' treatment. 
However further investigation is needed regarding this point because basically due to the small 
size of sample of the upper degrees where the number of masters holders are 7 and the number of 
certificates Doctorate  holders are  only 2 degree holders. 
Attending conferences related to diabetes hasn’t played a significant role in giving these services 
which means that pharmacists who attended the conference do not differ from pharmacists who 
did not attend conferences related to treatment of diabetic patients. 
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Being a part of an organization related to diabetes has also shown similar results to the point of 
attending conferences, which means that pharmacists who are participants in such organizations   
are not different from their colleagues of nonparticipant’s pharmacists. 
But when come into reading the medical journals about diabetes in periodic times, Pharmacists 
who used to read showed a significant difference over those who used not to read, especially 
with regard to the treatment of hypoglycemic patients, treatment of diseases associated with 
diabetes, in addition to the treatment of patients with diabetes who use oral medication and the 
early detection and prevention of diabetes treatment. 
The number of employees in the Pharmacists means that pharmacists do not differ in their role in 
the treatment of patients with diabetes depending on the number of employees in the pharmacy. 
But on the other hand the post-test groups heterogeneous LSD showed the existence of 
differences between the third group (more than 2 employees) and the second group (2 employees 
only) in the following four areas: glucose control in the blood and the treatment of diabetes, drug 
therapy for patients with diabetes who use insulin and the early detection of diabetes in favor of 
the existence of more than those working in the pharmacy. This could be due to the fact that all 
of the workers may think that his colleague had the expected role instead of him. 
Finally  this is to conclude that despite the fact that still the community pharmacy practice in 
Palestine toward chronic disease and diabetes management is still immature and  not 
programmatic but still there is a good opportunities to work on for favor of the patient care .  
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6.3 Limitations of the research 
 
Although this research was carefully prepared, limitations were inevitable for a number of 
reasons; firstly, the research was conducted in Hebron district only, which does not imply that it 
will be representative for the whole Palestinian territories and other Palestinian districts. 
Secondly; knowing that the sample was a convenient one; means it is of less strength than being 
implemented as a random one. Furthermore; the research targeted community pharmacists in 
their private pharmacies, but did not cover others pharmacists working in the public sector like 
hospitals, and clinics. 
 
6.4 Conclusion 
 
The main conclusions found throughout this thesis are as follows: 
1. Community pharmacists in Hebron district are experiencing a positive attitude and 
willing to help patients suffering from diabetes.  
2. Community pharmacists generally provide the service or answer questions asked by the 
patients. 
3. Community pharmacists do not differ in their role in the management and support given 
to diabetic patients based on different educational levels, or years of experience 
4. Time constraints and the lack of patient response to the advice was the most reported 
obstacles in providing diabetic services.  
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6.5 Recommendations 
 
Based on the research results and conclusions; the following recommendations are important to 
be applied on the national level: 
1. The importance of engagement of the community pharmacists in any future plan for 
treating and management possible life threats of diabetic patients 
2. There is a need from the health authorities and Pharmacists Association to improve the 
community pharmacists’ role in healthcare system by providing continuous education, 
support and awareness.  
3. The need to do awareness campaigns for the diabetic patients concerning the need of a 
specialized physician referrals.  
4. Awareness campaigns for diabetic patients to encourage them about asking their 
community pharmacists about diabetes and its treatments and control. 
5. National diabetes education programs should incorporate pharmacists as active 
participants by adapting established working models to the local needs and 
circumstances. 
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 eriannoitseuQ yevruS ,1 xennA
 استبيان عن دور الصيدلي في علاج مرضى السكري
 
 -المعلومات الديموغرافية : اولا :
 ------------ ---------العمر بالسنوات : 1-1
 الجنس     : 1 -2
 انثى  -ذكر                                             ب -أ      
 موقع الصيدلية  التي تعمل بها.: 1-3
 مدينة  -قرية                                        ب -أ
 جامعية للصيدلي :الدرجة ال 1 -4
 دكتوراه  -ماجستير                                            ج -بكالوريوس                                      ب –أ  
 
 هل انت بالنسبة للصيدلية  :1 -5
 موظف  -مالك                                          ب -أ
 مل المساعدين )  : _________________عدد العاملين بالصيدلية( يش 1 -6
 عدد سنوات الخبرة في ممارسة مهنه الصيدلة:_________________ 1-7
 هل تعمل في صيدلية اخرى : 1 -8
 لا  – 2نعم                         -1
 
  ثانيا : الممارسة الصيدلانية المتعلقة بمرضى السكري 
 
 
 لوقاية والعلاج من لمرضى السكري هل سبق وقمت بتلقي دورات تدريبية ل 2 1-
 لا –نعم                                 ب  -أ
 
 هل سبق وان حضرت مؤتمر خاص بعلاج مرضى السكري 2-2
 لا –نعم                                 ب    -ب
 
 
 
 64                                                                                                                                                                                                         
 
 هل تقوم بقراءة المجلات الطبية الخاصة بالمرض بشكل دوري ؟ 2-3
 لا –ب           نعم                          -أ
 
 هل انت مشارك بأي شكل من الاشكال في أي مؤسسة او جمعية لها دور في علاج المرض .2 4-
 لا –نعم                                 ب    -أ
 
 -ثالثا : الخدمات التي يوفرها الصيدلي لمرضى السكري : 
 -ها الصيادلة لمرضى السكري :)  تصف الخدمات التي يوفر  94-1العبارات التالي( من السؤال  
 ملاحظة : ( يرجى الاشارة الى النسبة المؤية  مراعيا المقاييس التالية ) 
 لا اوفر  : لا اوفر هذة الخدمة لمرضى السكري . -1
 % من المرضى .52نادرا : اقوم بتوفير هذة الخدمة ل  -2
 % من المرضى . 57كثير من الاحيان : اقوم بتوفير هذة الخدمة لحوالي  -3
 % من المرضى . 001دائما : اقوم بتوفير هذة الخدمة  لحوالي  -4
 
 
 الكشف المبكر والوقاية من مرض السكري 
 
 -اقوم  بشكل اعتيادي بعمل فحص دم للحالات الغير مشخصة بصيدليتي : -1
 
 دائما -د   كثيرا                            –نادرا                     ج  -لا اوفر                      ب -أ
 اقوم بتشخيص اعراض ثانوية للمرض بعد اكتشاف الحاله .. -2
 
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 لى تعديل نمط الحياه .. أقوم بتنبية الاشخاص المعرضين للإصابة بالمرض أو تشخيص مرحلة ما قبل السكري  وإرشادهم ا -3
 
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 انصح المرضى الذين يعانون من الوزن الزائد ، بتقليل الوزن عن طريق تقليل تناول الطعام .. -4
 دائما -كثيرا                              د –ج                  نادرا     -اوفر                      ب -أ
 
انصح جميع المرضى بتناول اطعمة ذات نسبة سكر منخفضة ( الفول , العدس , الشوفان , الفاكهه غير المحلاة ) كمصدر  -5
 للكبيوهديرات في وجباتهم 
 دائما -كثيرا                              د – نادرا                     ج -لا اوفر                      ب -أ
 
 مراقبه الجلوكوز بالدم  
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 اقوم بارشاد المرضى على كيفية استخدام فحص الدم البيتي , بما في ذلك كيفية اخذ عينة . -6
 ائما د-كثيرا                              د –نادرا                     ج  -لا اوفر                      ب  -أ
 
 اقوم بارشاد  المرضى على الاوقات المناسبة للتحقق من نسبة الجلوكوز بالدم . -7
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بارشاد المرضى على  النسبة الطبيعية للجلوكوز في الدم . -8
 دائما -كثيرا                              د –نادرا                     ج  -وفر                      بلا ا -أ
 
 C1A( اقوم بمساعد المرضى على تفسير قياسات  فحص السكري التراكمي ( -9
 دائما -د           كثيرا                    –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بتحديد الاسباب المحتملة للقيم الغير طبيعية للسكر في الدم . -01
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 ف المرجوة لنسبه السكر في الدم .اقدم  توصيات لعلاج الدوائي للطبيب لمساعده المرضى لبلوغ الاهدا -11
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 علاج هبوط السكر في الدم 
 اقوم بأرشاد المريض على علامات نقص السكر في الدم . -21
 دائما -كثيرا                              د –ج                      نادرا -لا اوفر                      ب -أ
 
 اقوم بتحديد الاسباب المحتملة لنقص السكري في الدم . -31
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 بات هبوط  السكر في الدم.اقوم بتحديد نسبة تردد  نو -41
 دائما -كثيرا                              د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بتقديم توصيات لعلاج هبوط  السكر في الدم. -51
 دائما -د                         كثيرا      –نادرا                     ج  -لا اوفر                      ب -أ
 
 
 العام  -العلاج الدوائي
 ) والذي يتضمن . YROTSIH GURDاجراء  تقييم تاريخي ( -61
 الادوية المقرونة بوصفه . -أ
 دائما -كثيرا                      د –نادرا                     ج  -لا اوفر                      ب -أ
 
 الطبيعية .المستحضرات العشبية و -ب
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ   
 
 ):CTOالادوية التي لا تحتاج الى وصفات طبية ( -ت
 دائما-د  كثيرا                       –نادرا                     ج  -لا اوفر                      ب -أ   
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 )  .CTOاقوم بأعلام المرضى عن محاذير الادوية الغير مصحوبة بوصفه طبيه ( -71
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 المرض .اقوم باعلام المرضى عن محاذير استخدام  المستحضرات العشبية  ذات صله بعلاج  -81
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ  
 
 تحديد العوائق التي تحول دون التقييد بالمواظبة على استعمال الدواء . -91
 دائما-د                  كثيرا       –نادرا                     ج  -لا اوفر                      ب -أ
 
 توفير النصائح التي تساعد على الالتزام بتناول الدواء في الاوقات المحدده. -02
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 العلاج الدوائي لمرضى السكري الذين يتعاطون انسولين : 
 قوم بارشاد المرضى على  الطريقه المناسبة لاستخدام حقن  الانسولين  وكيفيه التخلص منه .ا -12
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 كيفية التخلص منهااقوم  بإرشاد المرضى على الطريقه المناسبة لاستخدام اقلام الانسولين  و -22
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بأعلام المرضى عن كيفيه عمل الانسولين وعن الاختلافات الرئيسية بين مستحضرات الانسلوين . -32
 دائما-كثيرا                        د –ج                  نادرا     -لا اوفر                      ب -أ
 
لا اوفر                       -أاقوم بارشاد المرضى عن كيفيه تعاطي الانسلوين ( الموقع , والتوقيت  والتغيير  في موقع الحقن)   -42
 دائما-كثيرا                        د –نادرا                     ج  -ب
 
 بمرضى السكري الذين يتعاطون العلاج عن طريق الفم  خاص
 اقوم بوصف اليه  العمل  لادوية السكري التي تؤخذ عن الفم : -52
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 ن  الادوية : اعلام المريض بالوقت المناسب لتعاطي  هذا  النوع م -62
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اعلام  المريض بالأضرار الجانبية المحتملة لتناول هذا النوع من الادوية . -72
 دائما-را                        دكثي –نادرا                     ج  -لا اوفر                      ب -أ
 
 
 علاج الامراض المصاحبة لمرضى السكري 
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 niripsa g.e)teltalp -itnaاقوم بأرشاد المريض على التوصيات الحاليه  لعلاج مضاد  الصفيحيات ( -82
 دائما-دكثيرا                         –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بأرشاد المريض على النتائج الطبيعية للضغط الدم.. -92
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اشرح للمريض اهمية علاج ضغط الدم لمرضى السكري . -03
 دائما-كثيرا                        د –ج                  نادرا     -لا اوفر                      ب -أ
 
 اقوم بمراجعه قياسات دم المريض لتحديد القيم الغير طبيعية. -13
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 المريض للكشف عن اسباب ارتفاع الضغط(ان وجد ) اقوم بالسؤال عن الادوية التي يتعاطاها -23
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بارشاد المريض المصاب بالسكري عن القيم الطبيعية لمستوى الكولسترول في الدم. -33
 دائما-كثيرا                        د –نادرا                     ج  -ب   لا اوفر                    -أ
 
 اقوم بشرح الاثار السلبية للأكتئاب على مريض السكري . -43
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 على الكليتين .اقوم بشرح خطورة مرض السكري  -53
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
اقوم بأرشاد المريض على اهمية الفحص المنتظم لاعتلال الكلية .على سبيل المثال ( كيفيه عمل الفحص ، وأمكنة  -63
 الحصول على الفحص ) .
 دائما-كثيرا                        د –نادرا                     ج  -ب                 لا اوفر      -أ
 شرح  وظائف الكليتين والمراحل المختلفة  من امراض  الكلى .. -73
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 ن الادوية التي يستخدمها المريض للتعرف على الانواع التي يتم التخلص منها عن طريق الكلية.السؤال ع -83
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بشرح خطر مرض السكري على اعتلال شبكية العين .  -93
 دائما-كثيرا                        د –نادرا                     ج  -ب                 لا اوفر      -أ
 
 ارشاد المريض على اهمية القيام بفحوصات دورية للحفاظ على شبكية العين . – 21
 دائما-دكثيرا                         –نادرا                     ج  -لا اوفر                      ب -أ
 
 ) المصاحب لمرض السكري .  yhtaporuen citebaidارشاد المريض على  اعراض خدر الاطراف( -04
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
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 الاطراف .ارشاد المريض على اهمية عمل الفحوصات الدورية للكشف عن اعراض خدر  -14
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 ارشاد المريض عن اهمية العناية بالقدم . -24
 ادائم-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ    
 الحياة الصحية لمرضى السكري :
 توعيه المرضى المدخنين عن خطورة استمرارهم بالتدخين . -34
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 ارشاد المرضى المدخنين على الوسائل المساعده عن  الاقلاع على التدخين . -44
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 توعية المرضى على اهمية اخد تطعيم الانفلونزا لمرضى السكري    -54
 دائما-دكثيرا                         –نادرا                     ج  -لا اوفر                      ب -أ
 
 توعية المريض على اهمية العناية بالأسنان وعمل فحوصات دورية للأسنان  -64
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 تقديم معلومات اساسية عن اهمية الحمية الغذائية لمرضى السكري . -74
 دائما-كثيرا                        د –نادرا                     ج  -ب                لا اوفر       -أ
 
 تقديم معلومات اساسية عن  الرياضه واثرها الايجابي على مرضى السكري . -84
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اقوم بإرشاد مرضى السكري على مايلي : -94
 برنامج تعليمي عن  المرض : -1
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 خبير تغذيه : -2
 دائما-د                 كثيرا        –نادرا                     ج  -لا اوفر                      ب -أ
 
 طبيب عيون : -3
 دائما-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
 
 اخصائي اجتماعي : -4
 ئمادا-كثيرا                        د –نادرا                     ج  -لا اوفر                      ب -أ
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هل يوجد خدمات اخرى تقوم بتقديمها  لمرضى السكري  لم يتم ذكرها في الاستبيان وماهي  تلك الخدمات ان  -05
 وجدت :
 _____________________________________________________
 
 _____________________________________________________
 
 
تقديم  العلاج المناسب لمرضى السكري ( الرجاء اختيار اجابه واحده من في رأيك ما هو العائق الاساسي في عدم  -15
 الاتي ) 
 ضيق الوقت . -1
 نقص التدريب . -2
 غياب الحوافز .  -3
 عدم استجابة المريض للنصح . -4
 عوامل اخرى ( الرجاء ذكرها ): -5
 
 
 
 
 مع فائق  الاحترام والشكر
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Annex2, Tables of surveys’ statistical analysis 
Reference to the designed survey questionnaire attached in annex 1, a statistical analysis was 
performed to analyze the collected responses. 
Through the annex, tables are listed to present the used variables and resulted analysis for each 
group of questions:   
Table (1):operational variables 
The research depends on the following main variable 
1 Age Refers to the age of the community pharmacists 
2 Gender Refers to the gender of the community pharmacist 
3 Practice Refers to the ways in which they demonstrate their knowledge and attitude 
through their actions for diabetes practice.  
4 Years of experience Refers to the years of experience gained by the community pharmacist as 
working in the community pharmacy . 
5 University degree   Refers to the certificate that the community pharmacy have 
(BA,Master,Phd) . 
6 Size of staff Indicated number of workers at the community pharmacy in which the 
selected community pharmacist works 
7 Previous training in diabetes 
management 
Indicated wither the community pharmacist has /hasn’t previous training 
experience in diabetes management. 
8 Employer vs. employee at the 
pharmacy 
Indicated if the community pharmacist is an employee /or employer for the 
community pharmacy 
9 Urban vs rural community 
pharmacists 
Indicates wither the community pharmacy is from the urban or the rural 
area of Hebron district . 
10 Sources of knowledge the source which the community pharmacist majorly depends on his 
knowledge of diabetes (medical journal, conferences, university) 
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Pharmaceutical practice 
Table (2):Pharmaceutical practice related to diabetes 
Percent 100% Number Level Variable 
26 26 Yes Training Period(course) 
74 74 No 
100 100 Total 
36 36 Yes Conference Attendance 
63 63 No 
99 99 Total 
1 1 Missing System 
100 100 Total 
47 47 Yes Medical Journal Reading 
53 53 No 
100 100 Total 
20 20 Yes Society Participation 
80 80 No 
100 100 Total 
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Table (3):  Activities held by pharmacists toward diabetic patients 
Degree Order SD Mean N Item Item 
No. 
Often 1 2.122 3.17 96 Guide the patients about the importance of foot 
care. 
42 
Often 2 .807 3.04 99  tuiding the patietnts aboug blood glucose normal 
values 
8 
Often 3 .787 3.03 96  Providing basic information about the importance 
of diet for diabetic patients 
47 
Often 4 .731 3.01 100 nforming the patient about the proper time of 
taking diabtis medications 
26 
Often 5 .835 2.98 97 Provide basic information about sports and its 
positive impact on patients with diabetes. 
48 
Often 6 .885 2.94 100 I do patients guidance on the appropriate way to 
use insulin injections and how to get rid of it. 
21 
Often 7 .678 2.94 100 Explain the importance of management high blood 
pressure on patients with diabetes 
30 
Often 8 .895 2.92 99 Counsel on the appropriate use of syringes and 
needles (e.g., sharpdisposal). 
22 
Often 9 .787 2.92 100 Counsel on the risk factors  for retinopathy in 
diabetes 
39 
Often 10 .829 2.91 99 Folk patients’ guidance on the appropriate times to 
check blood glucose. 
7 
Often 11 .782 2.91 98 Provide smokers with education on the risks of 
continued tobacco use. 
43 
Often 12 .829 2.91 100 Counsel on signs and symptoms of hypoglycemia 12 
Often 13 .611 2.90 100 Review the patient’s recent blood pressure 
measurements to identify 
abnormal values 
29 
Often 14 .826 2.89 99 Counsel on the use of a blood glucose meter, 
including how to obtain a blood 
Sample. 
6 
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Often 15 .895 2.89 97 Counsel on the appropriate use of insulin pens 24 
Often 16 .764 2.89 100  Provide patient-specific interventions to help 
improve adherence. 
20 
Often 17 .823 2.88 95  Counsel on the symptoms of neuropathic pain. 40 
Often 18 2.011 2.88 100 Describe the mechanism of action for each oral 
anti diabetic drug. 
25 
Often 19 .836 2.87 96 Provide education on the importance of regular 
screening for neuropathicpain. 
41 
Often 20 .797 2.86 94 Guiding the patient about the signs of 
Hypolglycemia 
12 
Often 21 .800 2.84 99 Counsel on the risk factors for nephropathy in 
diabetes. 
35 
Often 22 .812 2.84 99 Describe potential adverse effects of each oral anti 
diabetic drug. 
27 
Often 23 .791 2.84 98 Identify possible causes of hypoglycemia 13 
Often 24 .804 2.84 98 Counsel on the current treatment targets for 
cholesterol in diabetes 
33 
Often 25 .837 2.84 100 Recommend to the patients who suffer from 
overweight, reduce weight by reducing eat 
4 
Often 26 .853 2.83 100 Counsel on how insulin works and the key 
differences amongst insulin 
formulations 
23 
Often 27 .821 2.82 99 Provide recommendations for treatment of 
hypoglycemia to the patient 
15 
Often 28 .703 2.82 98 Counsel about the cautions of over-the-counter 
drugs as they relate to 
diabetes management. 
17 
Often 29 .821 2.82 100 Review the patient’s drug profile to identify causes 
of abnormal blood 
pressure 
32 
Often 30 .944 2.80 99 Refereeing the patient to an ophthalmologist  49.3 
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Often 31 .853 2.79 97 Provide education on the effect depression can 
have on diabetes 
management 
44 
Often 32 .798 2.78 100 advise patients to eat foods with low percentage of 
sugar 
5 
Often 33 .805 2.76 99 Identify potential causes of abnormal blood 
glucose values 
10 
Often 34 .890 2.76 99 Counsel on the interpretation of A1C results 9 
Often 35 .904 2.75 99 Provide education on the importance of regular 
screening for nephropathy 
36 
Often 36 .803 2.74 98 Counsel about the cautions of herbal products as 
they relate to diabetes management 
18 
Often 37 .728 2.71 100 Identify the  barriers to good drug adherence 19 
Often 38 .899 2.67 100 Identify frequency of hypoglycemic episodes 14 
Often 39 .860 2.66 98 Provide education about the importance of 
immunization for influenza and pneumococcal 
pneumonia in diabetes 
45 
Often 40 .743 2.65 100 Counsel on current recommendations for 
antiplatelet therapy (e.g., low doseacetylsalicylic 
acid). 
28 
Often 41 .824 2.63 100 I alert the people exposed to the disease or 
diagnosed of pre-diabetes stage and guide them to 
modify their life style 
3 
Often 42 .804 2.60 95 Asking about Drug history 16c 
Often 43 .902 2.59 99 Review the patient’s drug profile to identify drugs 
that are renally cleared 
38 
Often 44 .868 2.59 99 Counsel on appropriate insulin administration 
(mixing insulin, injectiontechnique, timing of 
injection, rotation of sites). 
34 
Often 45 .917 2.59 98 Provide education about the importance of regular 
teeth brushing, flossing 
46 
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and dental examinations in diabetes. 
Often 46 1.011 2.57 99 Provide recommendations for treatment of 
hypoglycemia to the patient 
11 
Often 47 .900 2.56 97 Historical evaluation for prescribed medications. 16a 
Often 48 .891 2.55 100  Review the patient’s recent blood pressure 
measurements to identify 
abnormal values. 
31 
Often 49 .910 2.54 98 Counsel on renal function and the various stages of 
renal disease. 
37 
Seldom 50 .879 2.37 98 Herbal and natural products 16b 
Seldom 51 .835 2.36 100 diagnosis of secondary symptoms of the disease 
after the discovery of the case 
2 
Seldom 52 1.356 2.29 98 I do refer the patient to a social worker 49.4 
Seldom 53 .958 2.26 98 I do refer the patient to a nutrotuinist  49.2 
Seldom 54 .958 2.17 99 ram I do refer the patient to an education prog
concerning diabetis  
49.1 
Seldom 55 .942 2.02 100 I do  routinely check the blood glucose for the 
undiagnosed cases in the pharmacy 
1 
Often  O.59 2.79 63 Pharmacy Total Role 
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Table(4),practices related to Early detection of new case  
 
The current practices of community pharmacists towards diabetes and diabetic patients in terms 
of: Early detection of new case Causes and consequences  
 
 
 
 
 
 
 
 
 
Degree Order Std. 
Deviation 
Mean N Item Item 
n. 
Often 25 .837 2.84 100 Advising patients who are overweight, reducing 
weight by reducing eat (food consumption) 
4 
Often 32 .798 2.78 100 advise all patients to eat foods with a low sugar 
levels (beans, lentils, oats, unsweetened fruit) as a 
source of Carbohydrate  in their diet 
5 
Often 41 .824 2.63 100 I alert the people exposed to the disease or 
diagnosed as pre-diabetes stage and guide them to 
make  lifestyle modifications 
3 
Seldom 51 .835 2.36 100 diagnosis of secondary symptoms of the disease 
after the discovery of the case 
2 
Seldom 55 .942 2.02 100 I do routinely check the blood glucose  for the 
undiagnosed cases in the pharmacy 
1 
Often  .711 2.5 100 Total degree 
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Table  (5),Practices related to  Monitoring of patient condition 
The current practices of community pharmacists towards diabetes and diabetic patients interms 
of:Monitoring of patient condition (glucose in blood) 
 
 
 
 
 
 
 
 
Degree Orde
r 
Std. 
Deviation 
Mean N Item Item 
n. 
Often 1 .807 3.04 99 Counsel on the current treatment targets 
for blood glucose 
8 
Often 2 .829 2.91 99 Counsel on the appropriate times to 
check blood glucose 
7 
Often 3 .826 2.89 99 Counsel on the use of a blood glucose meter, 
including how to obtain a blood sample. 
6 
Often 4 .805 2.76 99 Identify potential causes of abnormal 
blood glucose values 
10 
Often 5 .890 2.76 99 Counsel on the interpretation of A1C 
results 
9 
Often 6 1.011 2.57 99 recommend drug therapy for  doctor to 
help patients to achieve the desired goals 
for blood glucose 
 
Often  O.738 2.82 100  Total Role 
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Table (6),Practices related to monitoring of patient condition (Hypoglycemia) 
The current practices of community pharmacists towards diabetes and diabetic patients in terms 
of:Monitoring of patient condition(Hypoglycemia) 
 
 
 
 
 
 
Table(7), Historical evaluation related to the use of drugs 
 
 
 
 
 
 
Degree Order 
Std. 
Deviation 
Mean N Item Item n. 
Often 1 .829 2.91 100 
Counsel on signs and symptoms of 
hypoglycemia. 
12 
Often 2 .791 2.84 98 Identify possible causes of hypoglycemia 13 
Often 3 .821 2.82 99 
Recommendations for treatment of 
hypoglycemia to the patient. 
15 
Often 4 .899 2.67 100 Identify frequency of hypoglycemic episodes 14 
Often .769 2.81 100 Total degree 
Degree Order Std. Deviation Mean N Item 
Item 
n. 
Often 1 .900 2.56 97 
Historical evaluation included 
prescribed medicine  
16a 
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Table (8): Counseling patients on the appropriate use of the medications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Degree Order SD Mean N Item 
Item 
no. 
Often 1 0.764 2.89 100 Provide patient-specific interventions to help improve 
adherence 
20 
Often 2 .703 2.82 98 Counsel about the cautions of over-the-counter drugs as they 
relate to diabetes management. 
17 
Often 3 .803 2.74 98 
Counsel about the cautions of herbal products as they relate to 
diabetes management 
18 
Often 4 .728 2.71 100 Identify the barriers for good drug adherence 19 
Often 5 .804 2.60 95 Over the counter medication  16c 
Often 6 .900 2.56 97 drug history review for medicatios that need a prescribtions  16a 
Seldom 7 .879 2.37 98 Asking about drug history for herbal medications  16b 
Often  O.627 2.66 100  Total degree 
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Table (9)Prescription and use of drugs(availability of anti diabetic medicines 
including insulin) 
 
 
Table (10) Prescription and use of drugs(availability of anti-diabetic 
medicines including insulin) 
 
Degree Order 
Std. 
Deviation 
Mean N Item 
Item 
n. 
Often 1 .885 2.94 100 Counsel on the appropriate use of syringes 
and needles (e.g., sharp disposal). 
21 
Often 2 .895 2.92 99 
Counsel on the appropriate use of syringes 
and needles (e.g., sharp 
disposal). 
22 
Often 3 .895 2.89 97 
Counsel on appropriate insulin administration 
(mixing insulin, injection technique, timing of 
injection, rotation of sites). 
24 
Often 4 .853 2.83 100 Counsel on how insulin works and the key 
differences amongst insulin formulations. 
23 
Often  .818 2.90 100 Total Degree 
Degree Order 
Std. 
Deviation 
Mean N Item Item n. 
Often 1 .731 3.01 100 
Describe the appropriate time to 
administer each oral anti diabetic drug 
26 
Often 2 2.011 2.88 100 Describe the mechanism of action for 
each oral anti diabetic drug. 
25 
Often 3 .812 2.84 99 
Describe potential adverse effects of 
each oral anti diabetic drug. 
27 
Often  O.918 2.90 100 Total Degree 
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Table (11), Dealing with complications 
 
 
Degree 
Orde
r 
Std. 
Deviation 
Mean N Item 
Item 
n. 
Often 1 .678 2.94 100 Provide education on the importance of controlling 
blood pressure in diabetes. 
30 
Often 2 .787 2.92 100 Counsel on the risk factors for retinopathy in 
diabetes. 
39.1 
Often 3 .611 2.90 100 Counsel on the current treatment targets for blood 
pressure in diabetes. 
29 
Often 4 .797 2.86 94 Provide education on the importance of regular 
screening for retinopathy 
39.2 
Often 5 .800 2.84 99 Counsel on the risk factors for nephropathy in 
diabetes. 
35 
Often 6 .804 2.84 98 Counsel on the current treatment targets for 
cholesterol in diabetes 
33 
Often 7 .821 2.82 100 Review the patient’s drug profile to identify causes 
of abnormal blood pressure. 
32 
Often 8 .904 2.75 99 
Provide education on the importance of regular 
screening for nephropathy (e.g., the type of test, 
where to get the test done, how often to test). 
36 
Often 9 .743 2.65 100 Counsel on current recommendations for anti 
platelet therapy (e.g., low dose acetylsalicylic acid). 
28 
Often 10 .902 2.59 99 Review the patient’s drug profile to identify drugs 
that are renal cleared 
38 
Often 11 .868 2.59 99 
Counsel on symptoms of depression. 
34 
Often 12 .891 2.55 100 Review the patient’s recent blood pressure 
measurements to identify abnormal values. 
31 
Often 13 .910 2.54 98 Counsel on renal function and the various stages of 
renal disease. 
37 
Often  O.640 2.75 100 Total Degree 
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Table (12), Foot care and Diabetic neuropathy 
 
Table (13), Monitoring of patient condition: 
life  style modification for the or the diabetic patients  
  
 
Degree Order 
Std. 
Deviation 
Mean N Item 
Item 
n. 
Often 1 2.122 3.17 96 
 Counsel on good foot care techniques. 
42 
Often 17 .823 2.88 95 Counsel on the symptoms of 
neuropathic pain 
40 
Often 19 .836 2.87 96 Provide education on the importance of 
regular screening for neuropathic pain. 
41 
Often  1.02 2.97 98 Total Degree 
Degree Order 
Std. 
Deviation 
Mean N Item 
Item 
n. 
Often 1 .787 3.03 96 Provide basic information on diet as it 
relates to diabetes management. 
47 
Often 2 .835 2.98 97  Provide basic information on exercise 
as it relates to diabetes management 
48 
Often 3 .782 2.91 98 Provide smokers with education on the 
risks of continued tobacco use. 
43 
Often 4 .853 2.79 97 Provide smokers with education on 
options to help with tobacco cessation 
44 
Often 5 .860 2.66 98 
Provide education about the importance 
of immunization for influenza and 
pneumococcal pneumonia in diabetes. 
45 
Often 6 .917 2.59 98 
Provide education about the importance 
of regular teeth brushing, flossing and 
dental examinations in diabetes. 
46 
Often  .695 2.83 99 Total Degree 
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Table (14), Referral of cases 
 
 
  
Degree Order SD Mean N Item 
Item 
n. 
Often 1 .944 2.80 99 
I do refer the patient to 
Ophthalmologist  
49c 
Seldom 2 1.356 2.29 98 
I do refer patient to social worker 
49d 
Seldom 3 .958 2.26 98 
I do refer patient to dietician  
49b 
Seldom 4 .958 2.17 99 I do refer patients to an educational 
program concerning diabetis  
49a 
Seldom  .838 2.38 99 Total Degree 
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Table( A)Main obstacles that impede pharmacists from giving diabetes 
services . 
 
Answering the question about the main obstacle in the absence of appropriate treatment for 
patients with diabetes 
Number Main obstacle  Frequencies  
1 time constraints 30 
2 Lack of patient response to the 
advice. 
31 
3 Lack  of incentive 13 
4 lack of training 11 
5 Lack of training and lack of 
patient response to advise  
4 
6 The lack of qualified medical 
teams. 
1 
7 Lack of patient’s follow up  2 
8 Lack   of programs for 
supporting diabetic patients  
1 
9 The existence of weak health 
care system that doesn’t offer 
the appropriate care for 
patients. 
1 
  94 
Missing answers  6 
Total answering   100 
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